Skip to content

Ayahuasca research published in 2024

Page 5 of 5: studies 81 to 95 of 95, newest first. Back to the ayahuasca overview

Studies

Síndrome serotoninérgico inducido por ayahuasca: a propósito de un caso

Revista chilena de neuro-psiquiatría 2024 M. Laura Ortega, D. Laura Herrera, U. Patricia Caro et al. 1 citation

RESUMEN El síndrome serotoninérgico es un conjunto de signos y síntomas generados por hiperactividad serotoninérgica, caracterizado principalmente por alteración del sistema nervioso central. La medicina tradicional, históricamente utiliza herbales con fines curativos y religiosos que podrían tener efectos sobre el sistema serotoninérgico, receptores de dopamina, glutamato y noradrenalina, en...

Potential therapeutic use of ayahuasca: A literature review

Acta Amazonica 2024 Salvana Priscylla Manso Costa, Keith Cardoso Carvalho, Isabella Nunes Gomes et al. 4 citations

ABSTRACT Ayahuasca is a psychoactive decoction originally used in indigenous Amazonian culture. It consists of a dense brown liquid that most frequently results from the decoction of two plants native to the Amazon rainforest, Psychotria viridis (Rubiaceae) and Banisteriopsis caapi (Malpighiaceae). The composition of the decoction is variable, as several plant species can be used in its...

Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study

Drug Science, Policy and Law 2024 Simon Ruffell, Sam Gandy, WaiFung Tsang et al. 10 citations

Indigenous Amazonian shamanic ayahuasca practice is embedded in a nature-based context and is employed as an ecological mediating agent and in collective environmental decision-making processes by some of the groups that use it. Phenomenologically, the ayahuasca experience is often rich in nature-based themes and content, and its usage has been associated with eliciting shifts in perspectives...

DOI: 10.1177/20503245241235100 (opens in new tab) Ayahuasca Amazonian Indigenous Amazon rainforest +1

Childhood trauma, challenging experiences, and posttraumatic growth in ayahuasca use

Drug Science, Policy and Law 2024 Ksenia Cassidy, C. J. Healy, Eva Henje et al. 10 citations

Challenging experiences in ayahuasca use, childhood trauma, and posttraumatic growth have not been investigated systematically. This study aimed to explore whether a self-reported history of childhood trauma was associated with challenging experiences during acute ayahuasca effects and whether such challenging experiences were associated with beneficial long-term outcomes measured by...

DOI: 10.1177/20503245241238316 (opens in new tab) Ayahuasca Adverse childhood experiences Intervention counseling Posttraumatic growth +4

Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.

Journal of Psychoactive Drugs 2024 Kelan Thomas, Robert L. Jesse, Nicky J. Mehtani et al. 4 citations

In recent years, policymakers have proposed and implemented regulatory changes promoting the deprioritization, decriminalization, or state-level legalization of one or more psychedelic substances, usually referencing data from clinical trials as reasons to support liberalizing drug control policies. As psychedelic policies continue to be drafted, personal possession limits may be considered for...

Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review.

Journal of Addictive Diseases 2024 Alexandra Arenson, Cynthia I Campbell, Ilan Remler 8 citations

The opioid epidemic and limited access to treatment for opioid withdrawal (OW) and opioid use disorder (OUD) has led individuals to seek alternative treatments. This narrative review aims to educate clinicians on the mechanisms of action, toxicity, and applications of psychoactive plant-based substances patients may be using to self-treat OUD and OW. We specifically discuss ayahuasca, ibogaine,...

Psychological and physiological effects of extended DMT.

Journal of Psychopharmacology 2024 Lisa Luan, Emma Eckernäs, Michael Ashton et al. 41 citations

N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic that induces a rapid and transient altered state of consciousness when inhaled or injected via bolus administration. Its marked and novel subjective effects make DMT a powerful tool for the neuroscientific study of consciousness and preliminary results show its potential role in treating mental health conditions. In a within-subjects,...

Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders.

Eating Disorders 2024 Meris Williams, Annie Kingston Miller, Adele Lafrance 6 citations

Eating disorders (EDs) are difficult conditions to resolve, necessitating novel treatments. Ayahuasca, a psychedelic plant medicine originating in Indigenous Amazonian communities, is being investigated. Aspects of ceremonial ayahuasca use (purging, dietary restrictions) appear similar to ED behaviors, raising questions about ayahuasca's suitability as an intervention for individuals with EDs....

DOI: 10.1080/10640266.2023.2271201 (opens in new tab) Full text (opens in new tab) Indigenous medicine Traditional healing Ayahuasca medicine Eating disorders treatment +1

Shared functional connectome fingerprints following ritualistic ayahuasca intake.

Neuroimage 2024 Pablo Mallaroni, Natasha L. Mason, Lilian Kloft et al. 17 citations

The knowledge that brain functional connectomes are unique and reliable has enabled behaviourally relevant inferences at a subject level. However, whether such "fingerprints" persist under altered states of consciousness is unknown. Ayahuasca is a potent serotonergic psychedelic which produces a widespread dysregulation of functional connectivity. Used communally in religious ceremonies, its...

DOI: 10.1016/j.neuroimage.2023.120480 (opens in new tab) Full text (opens in new tab) DMT Entheogens Brain connectivity connectome Neuroimaging FMRI +8

Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review.

International journal of toxicology 2024 Eleanor White, Tom Kennedy, Simon Ruffell et al. 13 citations

The objective of this paper is to conduct a systematic thematic review of adverse events, safety, and toxicity of traditional ayahuasca plant preparations and its main psychoactive alkaloids (dimethyltryptamine [DMT], harmine, harmaline, and tetrahydroharmine), including discussing clinical considerations (within clinical trials or approved settings). A systematic literature search of...

DOI: 10.1177/10915818241230916 (opens in new tab) Full text (opens in new tab) Adverse events Hallucinogens Ayahuasca safety: ayahuasca Good safety profile +6

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees.

Frontiers in Psychiatry 2024 Matthew X. Lowe, Hannes Kettner, Del R. P. Jolly et al. 9 citations

Refugees and immigrants can experience complex stressors from the process of immigration that can have lasting and severe long-term mental health consequences. Experiences after ayahuasca ingestion are shown to produce positive effects on psychological wellbeing and mental health, including anecdotal reports of improved symptoms of trauma and related disorders. However, data on the longitudinal...

The mitogenomic landscape of Banisteriopsis caapi (Malpighiaceae), the sacred liana used for ayahuasca preparation.

Genetics and molecular biology 2024 Edisson Chavarro-Mesa, João Victor Dos Anjos Almeida, Saura R Silva et al. 2 citations

The sacred ayahuasca brew, utilized by indigenous communities in the Amazon and syncretic religious groups in Brazil, primarily consists of a decoction of two plants: (i) the Amazonian liana known as Mariri or Jagube (Banisteriopsis caapi), and (ii) the shrub referred as Chacrona or Rainha (Psychotria viridis). While Chacrona leaves are rich in N,N-Dimethyltryptamine (DMT), a potent...

DOI: 10.1590/1678-4685-gmb-2023-0301 (opens in new tab) Full text (opens in new tab) Psychedelics Genetics Amazonian plants Ethnobotany +1

Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).

Advances in experimental medicine and biology 2024 Berend Olivier, Jocelien D A Olivier 11 citations

Major depressive disorder (MDD) is a highly prevalent psychiatric disorder, associated with substantial burden and large economical costs. Notwithstanding various conventional antidepressant treatment options, a large portion of depressed people (ca. 30%) fails to respond to first-line treatment, resulting in treatment-resistant depression (TRD). Although non-response to multiple antidepressant...

Ayahuasca for the treatment of alcohol use disorder.

International review of neurobiology 2024 Eduardo A V Marinho, Yasmim A. Serra, Alexandre J. Oliveira-Lima et al. 6 citations

For decades, psychedelics have been investigated for the treatment of psychiatric disorders. Specifically, evidence suggests that psychedelics may have therapeutic potential for the treatment of alcohol use disorder. Several studies with classic psychedelics, including LSD and psilocybin, show promising results, with psychedelics decreasing alcohol drinking and promoting abstinence in...

Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Frontiers in Psychiatry 2024 Pablo Sabucedo, Óscar Andión, Robert A Neimeyer et al. 4 citations

Psychotherapy for Prolonged Grief Disorder (PGD), a condition characterized by an intense and persistent grief response, has received increased attention over the past decades. Evidence-based approaches to prevent PGD are currently scarce, and not always effective. This paper introduces a protocol for a clinical trial exploring the effectiveness of a Meaning Reconstruction psychotherapy...